The Chronic Obstructive Pulmonary Disease (COPD) devices market is expected to see a steady increase in revenue from USD 8.3 billion in 2022 to USD 14.02 billion in 2032, with a Compound Annual Growth Rate (CAGR) of 6%. This growth is driven by several factors, including the increasing prevalence of COPD globally, a growing number of elderly people, and a rising demand for non-invasive devices....
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian